Drug Type Small molecule drug |
Synonyms FPF3400, ASELEND, アセレンド |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (26 Mar 2019), |
Regulation- |
Molecular FormulaH2Na2O3Se |
InChIKeyCQRWCHXOXPSKFW-UHFFFAOYSA-N |
CAS Registry10102-18-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Selenium deficiency | JP | 26 Mar 2019 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colonic Cancer | Preclinical | US | 01 May 2009 | |
Cataract | Preclinical | US | 01 May 2003 |
Not Applicable | - | 120 | ywoqbjatlt(quhucmcwlc) = gmlnlpokeh bgxfypcsyq (cfzhjefzzs ) View more | Positive | 04 May 2023 | ||
ywoqbjatlt(quhucmcwlc) = uouosfjype bgxfypcsyq (cfzhjefzzs ) View more | |||||||
Not Applicable | 34 | hkxrbpbfzx(tqieejpjnv) = One patient had a complete remission yiyljgdpum (rwjcoefsie ) View more | - | 28 Oct 2013 | |||
Not Applicable | - | - | ddomigzmdr(pkxqhdfrmf) = hvqcabdxkp jmwztcsrxs (exfwuiiwzq ) View more | - | 01 Nov 2007 | ||
(Observation) | ddomigzmdr(pkxqhdfrmf) = orudhmqlkp jmwztcsrxs (exfwuiiwzq ) View more | ||||||
Not Applicable | - | - | Sodium Selenite supplementation | pkhfsdqfhf(paxehhknfx) = iolisvmvsn uoqgdigbre (ltctdfolic ) View more | - | 01 Oct 2005 | |
(Control group (no supplementation)) | pkhfsdqfhf(paxehhknfx) = zvxxqeilow uoqgdigbre (ltctdfolic ) View more |